The purpose of this review is to focus on the three most important themes in genetic association studies using randomly selected patients (case, affected) and normal samples (control, unaffected), so that students and researchers alike who are new to this field may quickly grasp the key issues and command basic analysis methods. These three themes are: elementary categorical analysis; disease mutation as an unobserved entity; and the importance of homogeneity in genetic association analysis.
INTRODUCTION
Genetic association analyses, i.e. the examination of statistical correlation between a person's genetic marker genotype with his phenotype or disease status, has become a common task in human genetics and human disease studies. There are several reasons for this trend. First, it has been shown by statistical power analysis that genetic association studies require less samples than pedigree linkage analysis to map disease genes with low penetrance [1] . Second, with the genomic infrastructure in place, such as the complete DNA sequence of the human genome [2, 3] , the location of single-nucleotide-polymorphism (SNP) genetic markers [4, 5] , and the ever inexpensive high-throughput genotyping technologies [6, 7] , it is more cost-effective and easier to carry out candidate-gene, regional, or whole-genome association studies. Third, it has been discovered that the issue of population stratification and spurious association signal can be manageable if better study design is used and if serious care is taken during analysis [8] [9] [10] [11] . The publication of genome-wide association studies of seven common diseases using thousands of cases and controls from Wellcome Trust Case Control Consortium exemplified the current status of this field [12] .
A consequence of the rapid developments in the field of genetic association study is the large number of publications. Figure 1 shows the number of methodology papers on association analyses per year listed in the online bibliography maintained by the author (URL: http://www.nslij-genetics.org/ld/): it can be seen that after Risch and Merikangas's seminal paper in 1996, the number of methodology papers jumped to around 50 per year for the next three years. The next jump occurred in 2000-2001 with the anticipation and completion of the human genome project, to 100-180 papers per year. One may wait to see whether a publication peak has been reached in the past 2-3 years. For researchers and students new to this field, it is impractical to read 1500 method-oriented research articles, not to mention even more application papers. Reading all review articles is no less overwhelming. Here is just a partial list: Nature Reviews Genetics carried nearly 30 review articles related to association analysis one way or another, with the following among them: [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] ; Lancet published a series of review and introductory articles in 2005 on genetic epidemiology with association as the major component [23] [24] [25] [26] [27] [28] [29] ; Annual Review journals published many reviews that can be linked to association studies such as [30] [31] [32] [33] [34] [35] [36] [37] [38] , and Trends in Genetics [39] [40] [41] [42] [43] [44] [45] [46] occasionally publish reviews and perspectives on genetic association analysis.
To help a novice to digest this mountainous information, one solution is to limit the learning to only a few important topics or themes. The goal of this review is to focus on three such essential pieces of information that are required knowledge in genetic association: first, the necessary mathematical background; second, the fact that the disease-genemutation as well as the haplotype it resides is not directly observable; and third, the issue that heterogeneity of various forms is the most likely cause for false association signal. The following two review articles in [21, 47] are probably on a comparable level and readers can also consult the Handbook on Statistical Genetics in [48] .
LECTURE 1: STATISTICAL BACKGROUNDçCATEGORICAL DATA ANALYSIS
One commonly asked question is: what kind of mathematical background is needed for genetic association analysis? Due to the involvement of professional statisticians in the field, many sophisticated statistical and mathematical techniques have been applied. But the most basic tools used in association studies belong to the 'categorical data analysis' [49] , for the obvious reason that both the disease status and genotype are discrete and categorical.
The simplest scenario of genetic association analysis is to study a SNP's genotype frequency in a group of independent patients (cases) and a group of normal individuals (controls). This might be considered as the 'hydrogen atom' for genetic association, borrowing a term from physics to describe the minimum model system. Two types of questions can be asked concerning the genotype or allele frequency difference in the case and control groups. One is 'how big the genotype or allele frequency difference is?' Another is 'how likely that we see this genotype frequency difference by chance?' The first question is answered by 'estimation' and the second question by 'statistical testing.' The main difference between the two is that estimation is usually less affected by the sample size, whereas a test result is greatly influenced by how many samples are collected in the dataset. Later in this section, we will discuss the issue that precision of an estimation, the confidence interval, is also affected by the sample size.
After a routine test of Hardy-Weinberg equilibrium (which is explained in detail in both [47] and [21] ) in control samples for the purpose of revealing genotype errors [50] , allele and genotype frequency differences in the case and control groups can be tested for three tables: 2-by-3 genotype counts table,  2-by-2 allele counts table, and the 'better' of the two  2-by-2 genotype counts table by [21, 49] . CAT tests whether log(r), where r is the (number of cases)/(number of cases þ number of controls) ratio, changes linearly with the AA, AB, BB genotype with a non-zero slope. Note that since AB is positioned between AA and BB genotype, the genotype is not just a categorical variable, but an ordered categorical variable. Also note that although CAT is genotypebased, its value is closer to the allele-based ABT test statistic. This is confirmed by the numerical values in Figure 2 .
From Figure 2 , it can be seen that both the Pearson's chi-square test and Fisher's exact test lead to very similar results. The effect of sample size on test results can be easily demonstrated by multiplying all genotype counts by 2-even though the genotype frequencies as well as the difference between the two groups are unchanged, the test result becomes more significant (with much smaller P-values) when sample size is increased. The P-values obtained from GBT, ABT, MAX2, CAT tests are highly correlated, but not identical. Some differences between different tests were discussed in Ref. [55, 56] , but according to Ref. [21] , 'there is no generally accepted answer to the question of which SNP test to use'. The key issue seems to be that we do not know the true mode of inheritance of a disease with respect to a particular susceptibility gene and that information should help us to pick a particular test over other tests. The idea of combining two test statistics by a maximum operation as used in MAX2 test is a way to protect against uncertain disease model and this type of 'robust test' has been discussed in theoretical statistics [57, 58] .
As for the 'estimation' part of the association analysis, besides the genotype/allele frequency difference (e.g. for the data in Table 1 (panel B), the allele A frequency in case group is 210/2000 ¼ 10.5%, 
(C) Two ways of grouping heterozygotes with homozygotes
There are 1000 case samples and 1003 control samples, whose genotype distribution is shown in the table (A); the number of A and B allele counts is in (B). The genotype counts in (C) are converted from (A) by combining AB with either AA or BB. Note that the total counts in (B) doubles the counts in (A), and the two tables in (C) correspond to the dominant and recessive models if allele A is considered as the risk allele.
that in control group is 106/2006 ¼ 5.3%, differs by 5.2%), another commonly used quantity is oddsratio (OR). Odds itself is already a ratio: e.g. numbers of allele A ('for') versus numbers of allele that is not A ('against') can be used to estimate an odds . For the data in Table 1 (panel B), the odds for A in case group is estimated to be 210/ 1790 ¼ 0.117, and the odds for A in control group is estimated to be 106/1900 ¼ 0.056. If the allele A is rare, then odds is approximately equal to the allele frequency (e.g. 0.117 % 0.105 and 0.056 % 0.053). For the allele count data in Table 1 (panel B) the OR (case-over-control, for A) is 2.102878. Note that if we switch row and column, odds ('for' case, given a particular genotype) cannot be estimated, because in a case-control study design, the affection status is picked first and the genotype is determined later, so genotype is not given. For example, in the first table in Table 1 (panel A), we cannot say the odds 'for' case given AA genotype is 10:3, as the case samples always consist of a very small percentage of the general population, and this odds should be 1, not >1. However, a nice feature of case-control design is that even when odds cannot be defined when row and column are switched, the OR (A-over-B, 'for' case) can still be defined and unchanged by this operation.
There is one quantity that properly combines the 'estimation' and the 'testing' part of an analysis: the confidence interval (CI). We often see reports of the 95% confidence interval for odds-ratio (95% CI of OR), which means that if we repeat the same estimation of OR with the similarly generated data, 95% of the time the true value of OR would fall within that interval. The formula used for estimating CI of OR can be traced to Woolf [59, 60] , which is restated here [for the notation used, please refer to The number 1.96 comes from the normal distribution: the probability for sampling a standard normal distributed value within [À1.959964, 1.959964] is 95%. Similarly, there is a 99% chance to sample a standard normal random value within [À2.575829, 2.575829]. The estimation of confidence interval for OR is implemented in an R script in Figure 3 . Note that as expected, the 99% CI is wider than the 95% CI; also note that when the sample size is doubled, both CIs are narrowed.
LECTURE 2: DISEASE GENE MUTATION IS NOT DIRECTLY OBSERVABLE IN GENETIC ANALYSES
One of the important facts about genetic analysis is that we do not know directly the location of the disease gene, we only know the genetic markers nearby which might be in linkage disequilibrium with it; nor do we know directly the haplotype phase or the parental origin of the disease gene mutation. Some link between the observed and the hidden unobserved variable is needed. Table 2 (panel A) shows the four possible haplotypes with the disease locus and a SNP marker nearby, with haplotype frequencies of
, and wild-type allele frequency p h ¼ f 3 þ f 4 . Similarly, the marker allele frequencies are
The linkage disequilibrium (LD) is measured by a difference between the haplotype frequency and the product of independent allele frequencies and an obvious choice is: 
Disease locus
Freq Marker Freq Hapfreq.
The four haplotypes and their frequencies; (B) A special situation of three haplotypes ('three-haplotype scenario') where D 0 is always equal to 1.
There is a problem in using D, however: it depends on allele frequencies. Considering the following scenario ('three-haplotype scenario'): when the mutant allele H was first introduced into a population with the nearby marker allele A, most of haplotypes would be hÀA and hÀB, very few were HÀA, and none of the haplotypes were HÀB. Using the formula in Table 2 (panel B
For the three-haplotype scenario in Table 2 (panel B),
Is the maximum D 0 in the three-haplotype scenario the best we can hope for between a marker and the disease locus? If we detect the allele A in nearby marker, do we guarantee that there is a mutant allele in the disease locus? From Table 2 (panel B), the answer is no, because A can also sit on a haplotype with the wild-type allele h. In other words, the correlation between A and H is not 'perfect'. The correlation between A and H is maximized when the odds-ratio ðp H =p h Þ : ðp A =p B Þ is maximized, and the product of D 0 (squared) and this odds-ratio leads to a third measure of LD:
r 2 is equal to 1 (maximized) only when f 2 ¼ f 3 ¼ 0, or, when there is a one-to-one correspondence between allele A and mutant H. If both the disease locus and its nearby marker are coded numerically with H ¼ 1, h ¼ 0, A ¼ 1, B ¼ 0, then the covariance of the two variables is whose square is exactly r 2 . The r 2 is also related to a quantity widely used in information theory, the mutual information [62] :
This relationship (r 2 ¼ 2M assuming the natural log is used) can be proved by a Taylor expansion [49, [63] [64] [65] :
For a marker to be effective in genetic association study, its allele frequency difference in case and control groups has to be highly correlated with that for the disease gene locus. Let us put superscripts to allele and haplotype frequencies to distinguish cases from controls and define
for their differences. The notations p AjH ; p Ajh are used for the A allele frequency conditional on disease gene locus alleles.
If we assume p AjH
Þ remain approximately the same in case and control group and the superscript is not needed, then following Pritchard and Przeworski [34] :
For the Pearson's chi-square test, the chi-square test statistic X 2 is proportional to the square of the allele frequency difference, and inversely proportional to the product of two allele frequencies: X 2 $ ðÁpÞ 2 =ðpqÞ [34, 56] , so one implication of the above formula is:
i.e. the two chi-square test statistics, one at the disease locus and another at the SNP marker, are related by r 2 . Because this equation makes a crucial claim that test statistic at a nearby marker can be translated to that at the disease locus itself [15, 21, 34] , it can be called the 'fundamental formula for linkage disequilibrium mapping'. Other alternative versions of this fundamental formula can be found in Refs [66] [67] [68] .
A careful reader might notice that during the derivation of this fundamental formula, if the roles of A and H are switched, it leads to the incorrect conclusion of X HjA , because the first conditioning is to condition on the true cause of the disease status, whereas the second is only to condition on a 'hitchhiked' neutral marker, thus is unlikely to be true. However, how good the quality of the first approximation is may depend on whether there are other causes of the disease, i.e. other susceptibility loci or environmental factors unrelated to the region under study [67, 68] . Clearly more theoretical investigation of this issue is needed.
Besides the uncertainty of unobserved disease gene, the phase and parental origin of alleles are also not directly observable. However, methods exist to infer ('reconstruct') the haplotypes. One of the approaches, the EM (expectation and maximization) algorithm, will be introduced here, using the data in Table 3 (taken from Ref. [69] ) for joint genotype counts of two loci, one with alleles H and h, and one with alleles A and B.
The only samples whose phase cannot be unambiguously resolved are the double-heterozygous samples with the Hh-AB joint genotype. Of these samples, there are two possible phases: (i) H-A and h-B; (ii) H-B and h-A. We assume n 1 samples are in phase 1, and n 2 samples are in phase 2 (n 1 þ n 2 ¼ e). If n 1 and n 2 are known, then the haplotype frequencies f i ; f 2 ; f 3 ; f 4 can be determined as in Table 3 (panel B). On the other hand, if we know f 1 ; f 2 ; f 3 ; f 4 haplotype frequencies, n 1 should be proportional to f 1 f 4 , n 2 proportional to f 2 f 3 , and due to the constraint n 2 þ n 3 ¼ e, their value can be determined. This 'chicken and egg' problem can be tackled by first assuming a value for n 1 and n 2 (e.g., n 1 ¼ n 2 ¼ 2), solving for haplotype frequencies, using these haplotype frequencies to re-estimate n 1 ; n 2 , and repeating the iteration cycle until there is no improvement in the haplotype frequency estimation. An R-script of this process for the data in Table 3 (panel A) is included in Figure 4 .
This so-called EM algorithm [70] described above is also called 'gene counting' in genetics [71] and introductory material can be found in several textbooks [61, [72] [73] [74] . To recognize the situation where EM algorithm can be applied, remember the two key components in our example: missing data/ information (the number of double heterozygous samples in each phase: n 1 and n 2 ), and unknown parameters (the four haplotype frequencies:
. If the missing data can be estimated (imputed) when the parameter value is known (the E-step), and if the unknown parameter value can be obtained by the data (the M-step), the EM method is applicable. One final note is on a limitation of EM method [75] : if all our samples are double hetero-
, the limiting solution is not unique and dependent on the initial choice of n 1 ; n 2 . Intuitively, in this situation, we do not have any information to base on in order for deciding the phase of a double heterozygote, except to claim that each one of the four possible haplotypes has the same frequency. An alternative explanation of this limitation is that the application of EM requires Hardy-Weinberg 
(B) haplotype frequency when the phase of double-heterozygous samples is known
(A) Joint genotype counts originally used in Ref. [69] . (B) Two-locus haplotype counts if the double-heterozygous joint genotype counts (e) can be partitioned into e ¼ n 1 þn 2 , where n 1 (n 2 ) is the number of samples in the H-A, h-B phase (H-B, h-A phase) .
equilibrium, which is violated in the doubleheterozygous situation.
LECTURE 3:THE IMPORTANCE OF HOMOGENEITY
Concerns of population heterogeneity was the main reason that for many years the method of choice in genetic analysis was pedigree-based, i.e. linkage analysis and family-based association [76, 77] , and not the case-control association analysis. Spurious association signals due to population stratification occur if cases (or controls) disproportionally represent a genetically distinct subgroup and as a result, any allele frequency difference between this subgroup and the general population leads to an allele frequency difference between the case and the control group (see box 4 of Ref. [21] ). The effect of population stratification is an example of the 'aggregation paradox' [78] with Simpson's [79] (or Pearson-Yule-Kendall-Simpson's, to be historically correct [80] ) paradox as a special case. Simply stated, Simpson/aggregation paradox is the reversal/ inconsistency of a statistical relationship between two variables as observed in subpopulation, when subpopulations are combined into a whole population. In association analysis, the inconsistency caused by aggregation can be manifested in at least two different ways: (i) false positives-there is no observed association between a marker and the disease in subpopulations, whereas significant association is observed in the combined population; (ii) false negatives-marker-disease association exists in subpopulations but disappears in the combined population.
Instead of using tables to illustrate these two situations, here I am adopting a graphic technique previously used in the discussion of Simpson's paradox [81] . Figure 5 shows the allele frequencies in case and control groups in two subpopulations as well as in the combined population. The x-axis is the proportion of samples from subpopulation-1: left end corresponds to 100% subpopulation-2, and right end for 100% subpopulation-1. The y-axis is the allele frequency in case and control groups represented by two straight lines (here the case line is above the control line). Moving along the line changes the composition of samples from the two populations.
In Figure 5A , the control group has 40% of the samples from subpopulation-1, and 60% from subpopulation-2, but the case group has 90% subpopulation-1 samples and 10% subpopulation-2 samples. In each subpopulation, the allele frequency Table 3 (panel A) are stored in a 9-element array g. n 1 , n 2 are the missing data (number of double heterozygotes in phase 1 and phase 2), and f 1 , f 2 , f 3 , f 4 are the unknown parameter values (haplotype frequencies). Both the missing data and unknown parameter values are initialized before the while loop, and updated within the loop. The loop exit condition is when the iteration does not improve the parameter value estimation.
difference between the case and control group is 0.01, whereas in the combined dataset, the difference is increased to 0.21. At a typical sample size, testing allele frequency difference of 0.01 in each subpopulation will not be significant, but testing the 0.21 difference in the combined population will be significant. In fact, if the allele frequency in case and control groups is shrunk from 0.01 to 0 testing allele frequency in subpopulations will never be significant, whereas it could be significant in the combined population.
Using the graphic representation, we can easily figure out situations where population stratification has no effect. For example, if both lines in Figure 5A are horizontal, any composition of the two subpopulations leads to the same allele frequency difference in the combined population. In fact, it is the situation where two subpopulations have no differential allele frequency for this SNP. In another example, when the two lines are parallel to each other and the subpopulation compositions in case and control group are the same, then the allele frequency difference in the combined population remains the same as those in the subpopulations. It is the situation when the case and the control group are well matched in their subpopulation compositions.
False negatives caused by population stratification are rarely discussed in the genetic association literature, but can be easily illustrated by Figure 5B . In this example, the allele frequency difference between case and control group in the two subpopulations is 0.3 and 0.2, respectively. But with different compositions of the two subpopulations (80% subpopulation-1 for control group and 20% subpopulation-1 for case group), the allele frequency difference is merely 0.04 in the combined group.
One might think that since the compositions of two subpopulations in case and control usually do not differ very much, population stratification is unlikely to cause any problem. However, Figure 6 shows a real example in genetic association study of type 2 diabetes in American Indians [82] , where a 10% difference in subpopulation composition has lead to false positive signal. In Ref. [82] , a haplotype derived from allotypic markers (called Gm 3:5;13;14 ) is examined in American Indians with various degrees of Indian heritage. The Gm 3:5;13;14 -carrying frequency as a function of the Indian heritage (0 for European Caucasians, 7/8 for one non-Indian grand-grandparent, 1 for 100% Indian heritage, etc.) is shown in Figure 6 (crosses), which increases from 0.01 for 100% Indians to 0.66 for 100% Europeans), a dramatic change with the population proportion. Suppose the control group is 99% Indian and the diabetes group is 99.9% Indian, even if there is no difference between Gm 3:5;13;14 -carrying frequency in cases and controls, that in the combined dataset is expected to be 0.05. The numbers of 99% and 99.9% Indian in the control and the case group are not unrealistic since the prevalence of type 2 diabetes is higher in Indian population than that in European population, and it is more likely to sample a 100% Indian heritage case sample than a 100% Indian control sample.
The example in Figure 6 points to a way of protecting against population stratification effect: avoiding SNPs with large allele frequency differences between ethnic groups. How large a difference in allele frequency is considered to be large? Wright's F-statistic can be used for the purpose of measuring the effect of admixing subpopulations [83] . Denote the allele frequencies of an allele in two subpopulations as p 1 and p 2 (and for another allele, the frequencies are
. The heterozygosity (frequency of the heterozygote) in the two subpopulations is 2p 1 q 1 , 2p 2 q 2 , and that of the combined population is H whole ¼ 2p Á q, where p ¼ wp 1 þ ð1 À wÞp 2 , q ¼ wq 1 þ ð1 À wÞq 2 are the averaged allele frequency of the two alleles (with the mixing proportion of the two subpopulations being w and 1 À w).
If the heterozygosity is calculated within each subpopulation, and added with the appropriate weights, we have H sub ¼ w2p 1 q 1 þ ð1 À wÞ2p 2 q 2 . It turns out that heterozygosity always increases when subpopulations are combined, i.e. H whole ! H sub . We can illustrate this inequality for w ¼ 1=2:
The larger the allele frequency difference jp 1 À p 2 j, the bigger the inflation of heterozygosity in the combined population. The percentage increase of the heterozygosity by combining subpopulations is the Wright's F-statistic:
For more than two subpopulations, the formula is more complicated. Other meanings of F-statistic are discussed in detail in Ref. [83] . The F value can be marker-specific as well as dataset-specific, but an F ¼ 10 À1 seems to capture the typical variation between major ethnic groups (e.g. F for autosomal SNPs typed in HapMap between European and Chinese/Japanese is roughly 0.07, and that between Yoruba African and Chinese/ Japanese is 0.12 [4] ), and F ¼ 10 À4 $ 10 À3 seem to describe variation between regions of an isolated population (e.g. 0.00137 for 40 microsatellite markers between regions in the Icelandic population [84] ).
It is tempting to attribute the non-replication of association study results [85] [86] [87] 9 ] to population stratification, but it is not necessary to be the case [88, 89] . There are heterogeneities of other forms than that of the allele frequency. Locus heterogeneity refers to the situation in which the susceptibility gene can be located at different chromosomal locations for different patients. Allelic heterogeneity Figure 6 : A graphic illustration of the effect of population stratification in studying the potential association between Gm 3:5,13,14 and type 2 diabetes using American Indian samples. The Gm 3:5,13,14 -carrying probability as a function of non-Indian heritage is obtained from the data in Ref. [82] and shown in crosses. We also assume that the Gm 3:5,13,14 -carrying probability is practically the same between the case (type 2 diabetes) and the control group, indicated by the two straight lines. refers to the situation where mutations can occur anywhere in the same disease gene: coding, noncoding or regulatory regions. For example, it was found that there are three functional variants in the IFN regulatory factor 5 conveying risk for the disease systemic lupus erythematosus [90] . It is not impossible that this type of allelic heterogeneity could weaken the association signal to such an extent that the disease gene fails to be detected by an association study. Yet two other sources of heterogeneity are the disease subtypes and uncertainty in disease diagnosis. What is considered to be a single disease may have different etiologies involving different genes. From this perspective, the contribution of environmental factors can also vary from patients to patients, thus be called heterogeneous. It is with these complications caused by heterogeneity that the authors of Ref. [91] cautioned that 'homogeneous populations are not a panacea'. Common sense and care are perhaps the best weapon against errors caused by heterogeneity.
BEYOND THIS REVIEW
Even within the scope of the three themes covered in this review, not all topics are discussed. For Lecture 1, one might be interested in learning about power analysis (e.g. the power.prop.test subroutine in R) and multiple testing correction (Bonferroni correction for independent and correlated tests, false discovery rates, etc.). For Lecture 2, alternative ways for reconstructing haplotypes may be encountered [92] [93] [94] [95] , and one may also address the question of whether reconstructing haplotype step is truly necessary for LD mapping [21, 96, 97, 98] . For Lecture 3, one can study several proposals on correcting population stratifications using markers unlinked to the disease, such as the genomic control method [99, 100] and the one implemented in the STRUCTURE program [101] [102] [103] .
